Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.94 USD | +3.12% | -3.41% | -19.80% |
Mar. 20 | H.C. Wainwright Adjusts Price Target on Tango Therapeutics to $17 From $16, Keeps Buy Rating | MT |
Mar. 18 | Earnings Flash (TNGX) TANGO THERAPEUTICS Reports Q4 Revenue $5.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.80% | 847M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |
- Stock
- Equities
- Stock Tango Therapeutics, Inc. - Nasdaq
- News Tango Therapeutics, Inc.
- Tango Therapeutics : SVB Leerink Initiates Coverage on Tango Therapeutics With Outperform Rating, $25 Price Target